ONCOSIL MEDICAL LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0130 AUD | 0.00% |
|
+8.33% | +44.44% |
| Aug. 30 | OncoSil Medical Limited Appoints Peter Hall as Non-Executive Director | CI |
| Aug. 30 | OncoSil Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 30.35M | - | - | - | - | - | |
| 813B | ||||||
| 582B | ||||||
| 396B | ||||||
| 342B | ||||||
| 299B |
